Pharynx (Including Base of Tongue, Soft Palate, and Uvula)

Nonepithelial tumors such as those of lymphoid tissue, soft tissue, bone, and cartilage are not included
  • American Joint Committee on Cancer

Summary of Changes

For oropharynx and hypopharynx only, T4 lesions have been divided into T4a (resectable) and T4b (unresectable), leading to the division of Stage IV into Stage IVA, Stage IVB, and Stage IVC.


Squamous Cell Carcinoma Nasopharyngeal Carcinoma Soft Palate Pyriform Sinus AJCC Stage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ: Planned post-radiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 29:132–137, 1998CrossRefGoogle Scholar
  2. Chong V, Mukherji S, Ng S-H, et al: Nasopharyngeal carcinoma; review of how imaging affects staging. J Computer Assisted Tomography 23:984–993, 1999CrossRefGoogle Scholar
  3. Chua D, Sham J, Kwong D, et al: Prognostic value of parana-sopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis. Cancer 78:202–210, 1996PubMedCrossRefGoogle Scholar
  4. Colangelo LA, Logemann JA, Pauloski BR, Pelzer JR, Rademaker AW: T stage and functional outcome in oral and oropharyngeal cancer patients. Head Neck 18:259–268, 1996PubMedCrossRefGoogle Scholar
  5. Cooper J, Cohen R, Stevens R: A comparison of staging systems for nasopharyngeal carcinoma. Cancer 83:213–219, 1998PubMedCrossRefGoogle Scholar
  6. Deleyiannis FW, Weymuller EA Jr, Coltrera MD: Quality of life of disease-free survivors of advanced (Stage III or IV) oropharyngeal cancer. Head Neck 19:466–473, 1997PubMedCrossRefGoogle Scholar
  7. Forastiere AA, Trotti A. Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. J Nat Cancer Inst 91:2065–2066, 1999PubMedCrossRefGoogle Scholar
  8. Garden AS, Morrison WH, dayman GL, Ang KK, Peters LJ: Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease. Head Neck 18:317–22, 1996PubMedCrossRefGoogle Scholar
  9. Gwozdz JT, Morrison WH, Garden AS, Weber RS, Peters LJ, Ang KK: Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Rad Onc Biol Phys 39:127–135, 1997Google Scholar
  10. Harrison LB, Lee HJ, Pfister DG, Kraus DH, White C, Raben A, Zelefsky MJ, Strong EW, Shah JP: Long-term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of the tongue. Head Neck 20:668–673, 1998PubMedCrossRefGoogle Scholar
  11. Ho J: Stage classification of nasopharyngeal carcinoma, etiology and control. IARC Scientific Publications 20:99–113, 1978PubMedGoogle Scholar
  12. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen AM: Hypopharyngeal cancer patient care evaluation. Laryngoscope 107:1005–1017, 1997PubMedCrossRefGoogle Scholar
  13. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR: The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol-Head Neck Surg 951–962, 1998Google Scholar
  14. Iro H, Waldfahrer F: Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3,247 patients. Cancer 83:2201–2207, 1998PubMedCrossRefGoogle Scholar
  15. Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP: Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol-HN Surg 116,637–641, 1997CrossRefGoogle Scholar
  16. Lee A, Foo W, Law S, et al: N-staging of nasopharyngeal carcinoma: Discrepancy between UICC/AJCC and Ho systems. Clinical Oncology 17:377–381, 1995Google Scholar
  17. Lefebvre JL, Buisset E, Coche-Dequeant B, Van JT, Prevost B, Hecquet B, Damaille A: Epilarynx: pharynx or larynx? Head Neck 17:377–381, 1995PubMedCrossRefGoogle Scholar
  18. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatric A, Collette L, Sahmoud T: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Nat Cancer Inst 88:890–899, 1996PubMedCrossRefGoogle Scholar
  19. Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassissi NJ: Stratification of stage IV squamous cell carcinoma of the oropharynx. Head Neck 22:626–628, 2000PubMedCrossRefGoogle Scholar
  20. Pauloski BR, Logemann JA, Colangelo LA, Rademaker AW, McConnel FM, Heiser MA, Carndinale S, Shedd D, Stein D, Beery Q, Myers E, Lewin J, Haxer M, Esclamado R: Surgical variables affecting speech in treated patients with oral and oropharyngeal cancer. Laryngoscope 108:908–916, 1998PubMedCrossRefGoogle Scholar
  21. Perez CA, Patel MM, Chao KS, Simpson JR, Sessions D, Spector GJ, Haughey B, Lockett MA: Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Rad Onc, Biol Phys 42:1077–1084, 1998CrossRefGoogle Scholar
  22. Prehn RB, Pasic TR, Harari PM, Brown WD, Ford CN: Influence of computed tomography on pretherapeutic tumor staging of head and neck cancer patients. Otolaryngol-Head Neck Surg 199:628–633, 1998CrossRefGoogle Scholar
  23. Pugliano FA, Piccirillo JF, Zequeira MR, Emami B, Perez CA, Simpson JR, Frederickson JM: Clinical-severity staging system for oropharyngeal cancer: five-year survival rates. Arch Otolaryngol-Head Neck Surg 123:1118–1124, 1997PubMedCrossRefGoogle Scholar
  24. Righi PD, Kelley DJ, Ernst R, Deutsch MD, Gaskill-Shipley M, Wilson KM, Gluckman JL: Evaluation of prevertebral muscle invasion by squamous cell carcinoma. Can computed tomography replace open neck exploration? Arch Otolaryngol Head Neck Surg 122:660–663, 1996PubMedCrossRefGoogle Scholar
  25. Teresi L, Lufkin R, Vinuela F, et al: MR imaging of the nasopharynx and floor of the middle cranial fossa. Part II. Malignant Tumors. Radiol 164:817–821, 1987Google Scholar
  26. Thabet HM, Sessions DG, Gado MY, Gnepp DA, Harvey JE, Talaat M: Comparison of clinical evaluation and computed tomographic diagnostic accuracy for tumor of the larynx and hypopharynx. Laryngoscope 106:589–594, 1996PubMedCrossRefGoogle Scholar
  27. Veneroni S, Silvestrini R, Costa A, Salvatori P, Faranda A, Monlinari R: Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx. Oral Oncol 33:408–413, 1997PubMedCrossRefGoogle Scholar
  28. Wang MB, Kuber MM, Lee SP, Julliard GF, Abemayor E: Tonsillar carcinoma: analysis of treatment results. J Otolaryngol 27:263–269, 1998PubMedGoogle Scholar
  29. Wahlberg PC, Andersson KE, Biorklund AT, Moller TR: Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck 20:714–719, 1998PubMedCrossRefGoogle Scholar
  30. Weber RS, Gidley P, Morrison WH, Peters LJ, Hankins PD, Wolf P, Guillamondegui OM: Treatment selection for carcinoma of the base of the tongue. Am J Surg 60:415–419, 1990CrossRefGoogle Scholar
  31. Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW, Spiro RH, Bosl GJ, Harrison LB: Combined chemotherapy and radiotherapy versus surgical and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 18:405–411, 1996PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations